Stem Cell Treatment for Chronic Obstructive Pulmonary Disease (COPD)





Chronic obstructive pulmonary disease (COPD) is a progressive lung disease that makes it difficult to breathe.

According to the American Lung Association, over 16.4 million people in the United States have been diagnosed with the condition. However, it’s estimated that another 18 million people may have COPD and not know it.

The two main types of COPD are chronic bronchitis and emphysema. Many people with COPD have a combination of both.

There’s currently no cure for COPD. There are only treatments to improve quality of life and to slow the progression of the disease. However, there’s promising research that suggests stem cells may help treat this type of lung disease.

Stem cells 101

Stem cells are essential to every organism and share three main characteristics:

  • They can renew themselves through cell division.
  • Although they’re initially indistinguishable, they can differentiate themselves and take on the properties of several different structures and tissues, as the need arises.
  • They can be transplanted into another organism, where they will continue to divide and replicate.

To read the entire article, please click on the link below:


Stem Cell Therapy Treatment For COPD / Clinical Trial







Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide. COPD results from chronic inflammation of the lungs. Current treatments, including physical and chemical therapies, provide limited results. Stem cells, particularly mesenchymal stem cells (MSCs), are used to treat COPD. Here, we evaluated the safety and efficacy of umbilical cord-derived (UC)-MSCs for treating COPD.

To read the entire clinical trial, please click on the link below:

Allogeneic umbilical cord-derived mesenchymal stem cell transplantation for treating chronic obstructive pulmonary disease: a pilot clinical study (


Translate »